GE HealthCare announced Thursday the commercial launch of Flyrcado, its PET imaging agent that assesses blood flow to the heart muscle, in select U.S. markets. The Centers for Medicare and ...

The U.S. FDA’s approval of Telix Pharmaceuticals Ltd.’s kit for preparing prostate-specific membrane antigen-PET imaging for prostate cancer ... The FDA’s nod for the imaging agent, TLX007-CDx, now ...

Gozellix builds on the success of Telix’s established PSMA-PET imaging agent, Illuccix, and will be available alongside the first-generation product, providing choice for customers and patients based ...